Gloor E, Schnyder P, Cikes M, Hofstetter J, Cordey R, Burnier F, Knobel P
Cancer. 1982 Nov 1;50(9):1888-93. doi: 10.1002/1097-0142(19821101)50:9<1888::aid-cncr2820500940>3.0.co;2-k.
This report describes the clinicopathologic features of a 49-year-old woman who was reoperated on for bulky abdominal metastases 20 years after hysterectomy for endometrial stromal myosis (ESM). The levels of estrogen (ER) and progesterone (PR) receptors measured in the resected tumorous tissue amounted to 48.3 and 71.4 femtomoles (fmol)/mg cytosol protein, respectively. After medroxyprogesterone acetate (Depo-Provera; Upjohn) treatment of 16 months duration, the unresected pelvic tumor mass compressing the bladder and the left ureter had decreased in volume and hydroureteronephrosis had regressed. The efficacy of the therapy was monitored by computed tomography. Two years and nine months after surgery, the evolution of the tumor seems well-controlled by continuous progestin therapy and the patient is living without symptoms.
本报告描述了一名49岁女性的临床病理特征,该患者在因子宫内膜间质肌瘤(ESM)行子宫切除术后20年,因腹部巨大转移瘤接受再次手术。在切除的肿瘤组织中测得的雌激素(ER)和孕激素(PR)受体水平分别为48.3和71.4飞摩尔(fmol)/毫克胞浆蛋白。经16个月的醋酸甲羟孕酮(Depo-Provera;Upjohn)治疗后,未切除的盆腔肿瘤肿块压迫膀胱和左输尿管,体积减小,输尿管积水和肾积水消退。通过计算机断层扫描监测治疗效果。手术后两年零九个月,肿瘤的进展似乎通过持续的孕激素治疗得到了很好的控制,患者无症状生存。